the mean
[용어속성] Term
Attitudes and Satisfaction toward the Taken Procedures to Tackle COVID-19 Pandemic in Palestine
Original Article
[키워드] addition
Analysis
approach
Attitude
Attitudes
average
Characteristics
Community
conducted
Consequences
convenience sampling
COVID-19
COVID-19 infection
COVID-19 pandemic
cross-sectional
demonstrated
East
females
Gaza Strip
Government
implementation
IMPROVE
Jerusalem
Local
male
measure
Palestine
Participants
positive attitude
procedure
procedures
questionnaire
Result
Satisfaction
socio-demographic
SPSS
statistically significant
the mean
variable
Variation
was performed
was used
West Bank
while
[DOI] 10.4314/ejhs.v32i1.4 PMC 바로가기 [Article Type] Original Article
[DOI] 10.4314/ejhs.v32i1.4 PMC 바로가기 [Article Type] Original Article
Criteria for judging the immune markers of COVID‐19 disease vaccines
Original Article
[키워드] acute respiratory syndrome
adjusted
analyzed
antibody
assessment
boost
coronavirus
coronavirus disease
COVID‐19
disease
effective
Efficacy
evaluated
explained
IgG
immune marker
Immunoglobulin
inactivated
logistic regression model
Messenger RNA
mRNA
Neutralizing
Neutralizing antibodies
peaked
reached
receptor‐binding domain
reduce
Research
SARS‐CoV‐2
SARS‐CoV‐2
the mean
the vaccine
Vaccine
Vaccines
Viral vector vaccines
virus
[DOI] 10.1002/mco2.109 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1002/mco2.109 PMC 바로가기 [Article Type] Original Article
Efficacy of Tocilizumab in COVID-19: Single-Center Experience
Research Article
[키워드] addition
Admission
age
alanine aminotransferase
appear
C-reactive protein
Comorbidity
Course
COVID-19
COVID-19 patient
CRP
cut-off value
Cytokine release syndrome
Diagnosis
diagnosis of COVID-19
duration of symptom
effective
Effectiveness
Efficacy
experience
ferritin
Fever
first dose
Gender
hospital
Hospitalization
Hospitalized
include
intensive care
Laboratory
Lymphocyte count
male
median age
no difference
oxygen
Patient
required
Result
Retrospective study
significantly lower
statistically significant difference
survival group
survived
survivor
syndrome
TCZ
the mean
the mortality group
the patient
Tocilizumab
training
treated
Treatment
underlying diseases
university
were recorded
while
[DOI] 10.1155/2021/1934685 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/1934685 PMC 바로가기 [Article Type] Research Article
Efficacy of Tocilizumab in COVID-19: Single-Center Experience
Research Article
[키워드] addition
Admission
age
alanine aminotransferase
appear
C-reactive protein
Comorbidity
Course
COVID-19
COVID-19 patient
CRP
cut-off value
Cytokine release syndrome
Diagnosis
diagnosis of COVID-19
duration of symptom
effective
Effectiveness
Efficacy
experience
ferritin
Fever
first dose
Gender
hospital
Hospitalization
Hospitalized
include
intensive care
Laboratory
Lymphocyte count
male
median age
no difference
oxygen
Patient
required
Result
Retrospective study
significantly lower
statistically significant difference
survival group
survived
survivor
syndrome
TCZ
the mean
the mortality group
the patient
Tocilizumab
training
treated
Treatment
underlying diseases
university
were recorded
while
[DOI] 10.1155/2021/1934685 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/1934685 PMC 바로가기 [Article Type] Research Article
Efficacy of Tocilizumab in COVID-19: Single-Center Experience
COVID-19에서 Tocilizumab의 효능: 단일 센터 경험
Research Article
[키워드] addition
Admission
age
Alanine
alanine aminotransferase
appear
C-reactive protein
Comorbidity
Course
COVID-19
COVID-19 patient
CRP
cut-off value
Cytokine release syndrome
D-dimer
Diagnosis
diagnosis of COVID-19
dimer
duration of symptom
effective
Effectiveness
Efficacy
experience
ferritin
Fever
first dose
Gender
hospital
Hospitalization
Hospitalized
include
intensive care
intensive care unit
Laboratory
lymphocyte
Lymphocyte count
lymphocyte counts
male
median age
mortality group
no difference
oxygen
oxygen demand
Patient
required
Result
Retrospective study
saturation
significantly lower
start time
statistically significant difference
survival group
survived
survivor
syndrome
TCZ
the mean
the mortality group
the patient
Tocilizumab
training
treated
Treatment
two groups
underlying diseases
university
were recorded
while
[DOI] 10.1155/2021/1934685 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/1934685 PMC 바로가기 [Article Type] Research Article
Susceptibility of ABO blood group to COVID-19 infections: clinico-hematological, radiological, and complications analysis
4800
[키워드] abnormality
ABO
ABO blood group
Absolute lymphocyte count
Admitted Patient
age
Analysis
Asymptomatic
Blood
Blood Group
clinical information
commenced
Community
Complication
Computed tomography
conducted
COVID-19
COVID-19 disease
COVID-19 pandemic
COVID-19 patients
demographic
disease
disease manifestation
distribution
Evidence
Faisal
Glucose
groups
hematological
hematological parameters
Hospitalized
hospitalized COVID-19 patient
IgA
incidence
indicate
indicated
individual
Infection
infections
information
intensive care
Jeddah
King
Laboratory
majority
one-way ANOVA test
outcome
parameters
Patient
pharyngeal
Prognosis
progression
protocols
radiological
Research
retrospective cohort study
Saudi Arabia
Shortness of breath
specialist
statistically
statistically significant difference
study participant
susceptibility
Symptom
Symptoms
the mean
upper respiratory tract
X-ray
[DOI] 10.1097/MD.0000000000028334 PMC 바로가기 [Article Type] 4800
[DOI] 10.1097/MD.0000000000028334 PMC 바로가기 [Article Type] 4800
Quantitative Analysis of Performance Recovery in Semi-Professional Football Players after the COVID-19 Forced Rest Period
Article
[키워드] activities
Analysis
complete recovery
Contact
COVID-19
explosive and ballistic assessment
fatigue
Forced
Instrumental
lockdown
male
normalized
Observational data
outcome
outcomes
parameter
performance
performance recovery
Period
physical activity
physiological
protocol
questionnaire
significant effect
sport
the mean
variable
Variation
wearable sensors
were measured
Wilcoxon signed-rank test
[DOI] 10.3390/s22010242 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/s22010242 PMC 바로가기 [Article Type] Article
Provocation of dry eye disease symptoms during COVID-19 lockdown
Article
[키워드] 95% CI
age
conducted
contributed
Corneal diseases
COVID-19
COVID-19 outbreak
cross-sectional
demographics
diagnosed
disease
disease symptom
dropped
elicited
female gender
First wave
incidence
information
lockdown
measure
media
mental health
negative correlation
participant
questionnaire
reported
Risk factors
SARS-CoV-2
significantly
Symptom
Symptoms
the mean
worsening
[DOI] 10.1038/s41598-021-03887-4 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-03887-4 PMC 바로가기 [Article Type] Article